Insulin secretion and sensitivity in space flight: Diabetogenic effects

Nutrition

Volumn 18, Issue 10, 2002, Pages 842-848

  Tobin, Brian W ^a   Uchakin, Peter N ^a   Leeper Woodford, Sandra K ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amino acids; Diabetes; Disposition index; Glucose; Glucose tolerance; Insulin; Insulin resistance; Insulin secretion; Microgravity; Muscle; Nutrition; Protein; Space flight

Indexed keywords

INSULIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID METABOLISM; BIOREACTOR; CELL CULTURE; CYTOKINE PRODUCTION; DIABETOGENESIS; ENDOCRINE DISEASE; GENETIC DISORDER; HUMAN; HYPERINSULINEMIA; IMMUNOPATHOLOGY; IMPAIRED GLUCOSE TOLERANCE; INFECTION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LANGERHANS CELL; METABOLIC DISORDER; MICROGRAVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DISEASE; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; SPACE FLIGHT;

EID: 0036803353     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(02)00940-1     Document Type: Article

References (66)

1. Stein T.P., Schulter M.D., Boden G. Development of insulin resistance by astronauts during spaceflight. Aviat Space Environ Med. 65:1994;1091.
2. Dolkas C.B., Greenleaf J.E. Insulin and glucose responses during bed rest with isotonic and isometric exercise. J Appl Physiol. 43:1977;1033.
3. Maa H, Raabe W, Wegman HM. Effects of microgravity on glucose tolerance. Paper presented at the Norderney Symposium on Scientific Results of the German Spacelab Mission D-2, Norderney, Germany, March 14-16, 1994.
4. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002;25:S21.
5. Grigoriev AI. Man in space flight. Paper presented at the Third Nihon University International Symposium on Aerospace Science, Tokyo, Japan, 1990.
6. Lipman R.L., Ulvedal F., Schnure J.J., Bradley E.M., Lecocq F.R. Gluco-regulatory hormone response to 2-deoxy-d-glucose infusion in normal subjects at bedrest. Metabolism. 19:1970;980.
7. Piemme TE. Effects of two weeks of bed-rest on carbohydrate metabolism. Paper presented at the NASA Symposium on Hypogravity and Hypodynamic Environments, June 16-18, 1969.
8. Lipman R.L., Raskin P., Love T., et al. Glucose intolerance during decreased physical activity in man. Diabetes. 21:1972;101.
9. Lovejoy J.C., Smith S.R., Zachwieja J.J., et al. Low-dose T(3) improves the bed rest model of simulated weightlessness in men and women. Am J Physiol. 277:(2 pt 1):1999;E370.
10. Eisenbarth G.S., Connelly J., Soeldner J.S. The "natural" history of type I diabetes. Diabetes Metab Rev. 3:1987;873.
11. Goldman L., Bennet J.C., Cecil's textbook of medicine. 2001;WB Saunders, Philadelphia.
12. Ward W.K., Beard J.C., Porte D. Jr. Clinical aspects of islet B-cell function in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 2:1986;297.
13. Fiatarone M.A., Marks E.C., Ryan N.D., et al. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 263:1990;3029.
14. Frontera W.R., Hughes V.A., Lutz K.J., Evans W.J. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol. 71:1991;644.
15. Chandra R.K. Nutritional regulation of immunity and risk of infection in old age. Immunology. 67:1989;141.
16. Chen M., Halter J.B., Porte D. Jr. The role of dietary carbohydrate in the decreased glucose tolerance of the elderly. J Am Geriatr Soc. 35:1987;417.
17. Kahn S.E., Schwartz R.S., Porte D. Jr, Abrass I.B. The glucose intolerance of aging Implications for intervention . Hosp Pract (Off Ed). 26:(4A):1991;29.
18. Wylie-Rosett J., Edlen-Nezin L. Aging and weight control dietary management of diabetes . J Nutr Elder. 10:1991;7.
19. Andres R., Tobin J.D. Aging and the disposition of glucose. Adv Exp Med Biol. 61:1975;239.
20. Davidson M.B. The effect of aging on carbohydrate metabolism a review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly . Metabolism. 28:1979;688.
21. American Diabetes Association. Vital statistics 2001. Diabetes 2001;43.
22. Walsh C.H., Soler N.G., James H., et al. Studies in whole body potassium and whole body nitrogen in newly diagnosed diabetics. Q J Med. 45:(178):1976;295.
23. Nair K.S., Garrow J.S., Ford C., Mahler R.F., Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia. 25:1983;400.
24. Morgan H.E., Jefferson L.S., Wolpert E.B., Rannels D.E. Regulation of protein synthesis in heart muscle. II. Effect of amino acid levels and insulin on ribosomal aggregation. J Biol Chem. 246:1971;2163.
25. Jefferson L.S., Li J.B., Rannels S.R. Regulation by insulin of amino acid release and protein turnover in the perfused rat hemicorpus. J Biol Chem. 252:1977;1476.
26. Peavy D.E., Taylor J.M., Jefferson L.S. Correlation of albumin production rates and albumin mRNA levels in livers of normal, diabetic, and insulin-treated diabetic rats. Proc Natl Acad Sci USA. 75:1978;5879.
27. Froesch E.R., Guler H.P., Schmid C., Ernst M., Zapf J. Insulin-like growth factors. Rifkin H., Porte D., Ellenberg and Rifkin's diabetes mellitus: theory and practice. 1990;154 Elsevier Science, New York.
28. Lemozy S., Pucilowska J.B., Underwood L.E. Reduction of insulin-like growth factor-I (IGF-I) in protein-restricted rats is associated with differential regulation of IGF-binding protein messenger ribonucleic acids in liver and kidney, and peptides in liver and serum. Endocrinology. 135:1994;617.
29. Straus D.S. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB J. 8:1994;6.
30. Tobin B.W., Marchello M.J. Islet transplantation reverses carcass protein loss in diabetic rats without inducing disproportionate fat accumulation. Diabetologia. 38:1995;881.
31. Tobin B.W., Welch-Holland K.R., Marchello M.J. Pancreatic islet transplantation improves body composition, decreases energy intake and normalizes energy efficiency in previously diabetic female rats. J Nutr. 127:1997;1191.
32. Levin M.E., Boisseau V.C., Avioli L.V. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med. 294:1976;241.
33. Hough F.S. Alterations of bone and mineral metabolism in diabetes mellitus. Part I. An overview. S Afr Med J. 72:1987;116.
34. Goodman W.G., Hori M.T. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes. 33:1984;825.
35. Kim H.H. Characterization of the NF-kappaB activation induced by TR8, an osteoclastogenic tumor necrosis factor receptor family member. Arch Pharm Res. 22:1999;454.
36. Verbruggen A., De Clerck L.S., Bridts C.H., Van Offel J.F., Stevens W.J. Flow cytometrical determination of interleukin 1beta, interleukin 6 and tumour necrosis factor alpha in monocytes of rheumatoid arthritis patients; relation with parameters of osteoporosis. Cytokine. 11:1999;869.
37. Plotkin L.I., Weinstein R.S., Parfitt A.M., et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 104:1999;1363.
38. Riley D.A., Ellis S., Slocum G.R., et al. In-flight and postflight changes in skeletal muscles of SLS-1 and SLS-2 spaceflown rats. J Appl Physiol. 81:1996;133.
39. Stein T.P., Leskiw M.J., Schluter M.D. Diet and nitrogen metabolism during spaceflight on the shuttle. J Appl Physiol. 81:1996;82.
40. Lesnyak A., Sonnenfeld G., Avery L., et al. Effect of SLS-2 spaceflight on immunologic parameters of rats. J Appl Physiol. 81:1996;178.
41. Zerath E., Novikov V., Leblanc A., et al. Effects of spaceflight on bone mineralization in the rhesus monkey. J Appl Physiol. 81:1996;194.
42. Hotamisligil G.S., Budavari A., Murray D., Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 94:1994;1543.
43. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha a key component of the obesity-diabetes link . Diabetes. 43:1994;1271.
44. Leeper-Woodford S.K., Tobin B.W. Tumor necrosis factor activity of pancreatic islets. Am J Physiol. 273:(2 pt 1):1997;E433.
45. Yki-Jarvinen H., Koivisto V.A. Natural course of insulin resistance in type I diabetes. N Engl J Med. 315:1986;224.
46. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta- cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 42:1993;1663.
47. Argiles J.M., Lopez-Soriano J., Lopez-Soriano F.J. Cytokines and diabetes: the final step? Involvement of TNF-alpha in both type I and II diabetes mellitus. Horm Metab Res. 26:1994;447.
48. Sonnenfeld G., Gould C.L., Williams J., Mandel A.D. Inhibited interferon production after space flight. Acta Microbiol Hung. 35:1988;411.
49. Hughes-Fulford M., Lewis M.L. Effects of microgravity on osteoblast growth activation. Exp Cell Res. 224:1996;103.
50. Armstrong J.W., Gerren R.A., Chapes S.K. The effect of space and parabolic flight on macrophage hematopoiesis and function. Exp Cell Res. 216:1995;160.
51. Chapes S.K., Morrison D.R., Guikema J.A., Lewis M.L., Spooner B.S. Cytokine secretion by immune cells in space. J Leukoc Biol. 52:1992;104.
52. Unsworth B.R., Lelkes P.I. Growing tissues in microgravity. Nat Med. 4:1998;901.
53. Schwarz R.P., Goodwin T.J., Wolf D.A. Cell culture for three-dimensional modeling in rotating-wall vessels an application of simulated microgravity . J Tissue Cult Methods. 14:1992;51.
54. Tobin B.W., Leeper-Woodford S.K., Hashemi B.B., Smith S.M., Sams C.F. Altered TNF-alpha, glucose, insulin, and amino acids in islets of Langerhans cultured in a microgravity model system. Am J Physiol. 280:2001;E92.
55. Norman J.G., Fink G.W., Franz M.G. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg. 130:1995;966.
56. Toyoda H., Formby B., Magalong D., et al. In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse. Immunol Lett. 39:1994;283.
57. Leach C.S., Rambaut P.C. Biomedical responses of the Skylab crewman: an overview. 1977;Scientific and Technical Information Office National Aeronautics and Space Administration, Washington, DC.
58. Dunger A., Cunningham J.M., Delaney C.A., et al. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement. Diabetes. 45:1996;183.
59. Stein T.P., Leskiw M.J., Schluter M.D., Donaldson M.R., Larina I. Protein kinetics during and after long-duration spaceflight on MIR. Am J Physiol. 276:(6 pt 1):1999;E1014.
60. Stein T.P., Schluter M.D. Plasma amino acids during human spaceflight. Aviat Space Environ Med. 70:(3 pt 1):1999;250.
61. Malaisse W.J., Blachier F., Mourtada A., et al. Stimulus-secretion coupling of arginine-induced insulin release Metabolism of L-arginine and L-ornithine in pancreatic islets . Biochim Biophys Acta. 1013:1989;133.
62. Windmueller H.G. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 53:1982;201.
63. Bergman R.N., Phillips L.S., Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose . J Clin Invest. 68:1981;1456.
64. Johnson P.C., Doll S.C., Cromey D.W. Pathogenesis of diabetic neuropathy. Ann Neurol. 19:1986;450.
65. Crall F.V. Jr, Roberts W.C. The extramural and intramural coronary arteries in juvenile diabetes mellitus analysis of nine necropsy patients aged 19 to 38 years with onset of diabetes before age 15 years . Am J Med. 64:1978;221.
66. Paz-Guevara A.T., Hsu T.H., White P. Juvenile diabetes mellitus after forty years. Diabetes. 24:1975;559.